- Home
- EVO vs IRS Comparison
EVO vs IRS Comparison
Compare EVO & IRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVO
- IRS
- Stock Information
- Founded
- EVO 1993
- IRS 1943
- Country
- EVO Germany
- IRS Argentina
- Employees
- EVO N/A
- IRS N/A
- Industry
- EVO Biotechnology: Pharmaceutical Preparations
- IRS Homebuilding
- Sector
- EVO Health Care
- IRS Real Estate
- Exchange
- EVO Nasdaq
- IRS Nasdaq
- Market Cap
- EVO 1.2B
- IRS 959.8M
- IPO Year
- EVO 2021
- IRS 1994
- Fundamental
- Price
- EVO $3.93
- IRS $11.65
- Analyst Decision
- EVO Strong Buy
- IRS
- Analyst Count
- EVO 1
- IRS 0
- Target Price
- EVO $7.00
- IRS N/A
- AVG Volume (30 Days)
- EVO 44.7K
- IRS 298.3K
- Earning Date
- EVO 11-05-2025
- IRS 11-05-2025
- Dividend Yield
- EVO N/A
- IRS 8.83%
- EPS Growth
- EVO N/A
- IRS N/A
- EPS
- EVO N/A
- IRS 0.20
- Revenue
- EVO $912,894,891.00
- IRS $416,589,564.00
- Revenue This Year
- EVO N/A
- IRS N/A
- Revenue Next Year
- EVO $10.78
- IRS N/A
- P/E Ratio
- EVO N/A
- IRS $5.72
- Revenue Growth
- EVO N/A
- IRS N/A
- 52 Week Low
- EVO $2.84
- IRS $10.61
- 52 Week High
- EVO $5.64
- IRS $17.67
- Technical
- Relative Strength Index (RSI)
- EVO 59.84
- IRS 41.00
- Support Level
- EVO $3.93
- IRS $10.87
- Resistance Level
- EVO $4.02
- IRS $11.91
- Average True Range (ATR)
- EVO 0.08
- IRS 0.59
- MACD
- EVO 0.04
- IRS 0.03
- Stochastic Oscillator
- EVO 78.26
- IRS 36.73
About EVO Evotec SE
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
About IRS IRSA Inversiones Y Representaciones S.A. Global Depositary Shares (Each representing ten shares of)
IRSA Inversiones y Representaciones SA is engaged in a diversified business. The company's operating segment includes Shopping Malls; Offices; Sales and Developments; Hotels and others. It generates maximum revenue from the Shopping Malls segment. The Shopping Malls segment comprised of lease and service revenues related to rental of commercial space and other spaces in the shopping malls of the company.